March 3, 2023
PanJam Investment Limited (PJAM) for the year ended December 31, 2022, reported a 45% decrease in total income to total $2.35 billion relative to $4.30 billion booked for the prior year’s corresponding period. Of total income:
Investment loss amounted to $758.82 million relative to an investment gain of $2.06 billion in 2021.
Operating expenses amounted to $2.46 billion for the year ended December 31, 2022 (2021: $1.86 billion), 33% more than its total a year prior.
Consequently, operating loss amounted to $943.25 million relative to a profit $2.50 billion a year earlier.
Finance costs for the period rose by 12%, amounting to $1.03 billion compared to the $914.42 million for the comparable period in 2021.
Share of results of associated companies amounted to $4.96 billion relative to $5.46 billion in 2021.
Profit before taxation fell 40%, closing the period at $4.37 billion (2021: $7.23 billion). Taxation credit amounted to $420.63 million, relative to $20.57 million reported in the prior year. Net profit amounted to $4.79 billion (2021: $7.25 billion).
Net Profit Attributable to Shareholders for the period amounted to $4.75 billion a 34% decrease relative to the $7.20 billion recorded in 2021.
Total comprehensive income amounted to $1.02 billion relative to $5.91 billion a year prior.
Consequently, earnings per share for the period amounted to $4.45 (2021: $6.76). The number of shares used in the calculation is 1,066,159,890 units. Notably, PJAM’s stock traded on March 2, 2023 at a price of $57.10 with a corresponding P/E ratio of 12.83 times.
Balance Sheet at a glance:
As at December 31, 2022, PanJam Investment Limited (PJAM) had assets totaling $67.42 billion, a 1% decline relative to $67.77 billion a year prior. The fall was attributed to a decrease in ‘Deposits’ which closed at $8.28 billion (2021: $10.82 billion).
Shareholders Equity amounted to $51.77 billion (2021: $51.96 billion) with a book value per share of $48.56 (2021: $48.74).
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.